Featured Research

from universities, journals, and other organizations

Women More Vulnerable To Tobacco Carcinogens, New Results Show

Date:
May 7, 2009
Source:
European Society for Medical Oncology
Summary:
Women may be more vulnerable than men to the cancer-causing effects of smoking tobacco, according to new results.

Women may be more vulnerable than men to the cancer-causing effects of smoking tobacco, according to new results reported this week at the European Multidisciplinary Conference in Thoracic Oncology (EMCTO), Lugano, Switzerland.

Swiss researchers studied 683 lung cancer patients who were referred to a cancer centre in St Gallen between 2000 and 2005 and found women tended to be younger when they developed the cancer, despite having smoked on average significantly less than men.

"Our findings suggest that women may have an increased susceptibility to tobacco carcinogens," report Dr Martin Frueh and colleagues.

Dr Enriqueta Felip from Val d'Hebron University Hospital in Barcelona, Spain, conference co-chair, notes that the results support a growing awareness that smoking presents greater risks to women than men.

"In the early 1900s lung cancer was reported to be rare in women, but since the 1960s it has progressively reached epidemic proportions, becoming the leading cause of cancer deaths among women in the United States," Dr Felip said.

"Lung cancer is not only a man's disease, but women tend to be much more aware of other cancers, such as breast cancer," she said. "Several case-control studies seem to suggest that women are more vulnerable to tobacco carcinogens than men."

On the positive side, other research presented at the conference suggests that women tend to do better than men after surgery to remove lung tumors.

Irish researchers led by Dr Bassel Al-Alao studied 640 patients whose non-small-cell lung cancer was surgically removed over a 10-year period, 239 of whom were women.

They found that median survival after surgery was 2.1 years for men, and 4.7 years for women.


Story Source:

The above story is based on materials provided by European Society for Medical Oncology. Note: Materials may be edited for content and length.


Cite This Page:

European Society for Medical Oncology. "Women More Vulnerable To Tobacco Carcinogens, New Results Show." ScienceDaily. ScienceDaily, 7 May 2009. <www.sciencedaily.com/releases/2009/05/090503082340.htm>.
European Society for Medical Oncology. (2009, May 7). Women More Vulnerable To Tobacco Carcinogens, New Results Show. ScienceDaily. Retrieved October 1, 2014 from www.sciencedaily.com/releases/2009/05/090503082340.htm
European Society for Medical Oncology. "Women More Vulnerable To Tobacco Carcinogens, New Results Show." ScienceDaily. www.sciencedaily.com/releases/2009/05/090503082340.htm (accessed October 1, 2014).

Share This



More Health & Medicine News

Wednesday, October 1, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Some Positive Ebola News: Outbreak 'Contained' In Nigeria

Some Positive Ebola News: Outbreak 'Contained' In Nigeria

Newsy (Sep. 30, 2014) The CDC says a new case of Ebola has not been reported in Nigeria for more than 21 days, leading to hopes the outbreak might be nearing its end. Video provided by Newsy
Powered by NewsLook.com
UN Ebola Mission Head: Immediate Action Is Crucial

UN Ebola Mission Head: Immediate Action Is Crucial

AFP (Sep. 30, 2014) The newly appointed head of the United Nations Mission for Ebola Emergency Response (UNMEER), Anthony Banbury, outlines operations to tackle the virus. Duration: 00:39 Video provided by AFP
Powered by NewsLook.com
CDC Confirms First Case of Ebola in US

CDC Confirms First Case of Ebola in US

AP (Sep. 30, 2014) The CDC has confirmed the first diagnosed case of Ebola in the United States. The patient is being treated at a Dallas hospital after traveling earlier this month from Liberia. (Sept. 30) Video provided by AP
Powered by NewsLook.com
New Breast Cancer Drug Extends Lives In Clinical Trial

New Breast Cancer Drug Extends Lives In Clinical Trial

Newsy (Sep. 30, 2014) In a clinical trial, breast cancer patients lived an average of 15 months longer when they received new drug Perjeta along with Herceptin. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins